Key facts
- Nephrocare Health Services (NSE: NEPHROPLUS)’s last known valuation is $514.5M (Dec 2025).
- It has raised $267.3M across 1 recorded rounds; the latest was Later Stage VC (Series F) ($102.5M) in May 2024.
- Notable investors include International Finance (Washington D.C.), Quadria Capital, Kamet Capital, 360 ONE, Conifer Capital — 8 tracked in total.
- Status: Publicly Held.
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Nephrocare Health Services (NSE: NEPHROPLUS)
Funding rounds
1 roundsAbout Nephrocare Health Services (NSE: NEPHROPLUS)
Nephrocare Health Services Ltd is a dialysis services provider company. It offers comprehensive dialysis care through its network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. The company operates in a single segment, namely the provision of dialysis services and the sale of related healthcare products. It generates revenue by providing its dialysis and related services.
- Industry
- Clinics/Outpatient Services
- Sector
- Healthcare
- HQ
- Hyderabad, India
- Founded
- 2009
- Employees
- 5,850
- Website
- nephroplus.com/
- Ownership
- Publicly Held
Nephrocare Health Services (NSE: NEPHROPLUS) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nephrocare Health Services (NSE: NEPHROPLUS) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nephrocare Health Services (NSE: NEPHROPLUS) in its N-PORT filings yet. We sweep new filings monthly.